PUREOS BIOVENTURES
Pureos Bioventures is a new venture capital fund located in Zurich to exclusively invest in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats
PUREOS BIOVENTURES
Status:
Active
Technology used in webpage:
Google Universal Analytics Amazon PHP 7 Google Analytics Event Tracking Google Analytics IP Anonymization SwissSign
Similar Organizations
Flucas Ventures
Flucas Ventures is an active venture capital investor.
Pontaq
Pontaq is the first Venture Capital Fund manager focused on UK-India corridor, operating since 2015.
Current Employees Featured
Martin Münchbach Managing Partner & Founding Partner @ Pureos Bioventures
Managing Partner & Founding Partner
2017-01-01
Klaus Breiner Managing Partner & Founding partner @ Pureos Bioventures
Managing Partner & Founding partner
2017-01-01
Dominik Escher Managing Partner & Founding partner @ Pureos Bioventures
Managing Partner & Founding partner
2017-06-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-13 | ImCheck Therapeutics | Pureos Bioventures investment in Series C - ImCheck Therapeutics | 96 M EUR |
| 2022-06-08 | Ariceum Therapeutics | Pureos Bioventures investment in Series A - Ariceum Therapeutics | 25 M EUR |
| 2022-05-03 | Engimmune Therapeutics | Pureos Bioventures investment in Seed Round - Engimmune Therapeutics | 15.5 M CHF |
| 2021-11-11 | Acrivon Therapeutics | Pureos Bioventures investment in Series B - Acrivon Therapeutics | 100 M USD |
| 2021-06-15 | Alentis Therapeutics | Pureos Bioventures investment in Series B - Alentis Therapeutics | 60 M CHF |
| 2021-05-18 | Hummingbird Bioscience | Pureos Bioventures investment in Series C - Hummingbird Bioscience | 125 M USD |
| 2020-11-02 | Corlieve Therapeutics | Pureos Bioventures investment in Seed Round - Corlieve Therapeutics | N/A |
| 2020-10-22 | Araris Biotech | Pureos Bioventures investment in Seed Round - Araris Biotech | 15.2 M CHF |
| 2020-09-17 | Lava Therapeutics | Pureos Bioventures investment in Series C - Lava Therapeutics | 83 M USD |
| 2020-09-15 | ImCheck Therapeutics | Pureos Bioventures investment in Series B - ImCheck Therapeutics | 6 M EUR |
More informations about "Pureos Bioventures"
Pureos Bioventures - Crunchbase Investor Profile
Pureos Bioventures is a new venture capital fund located in Zurich to exclusively invest in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. Lists Featuring …See details»
Pureos Bioventures - LinkedIn
Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and ...See details»
Pureos Bioventures – Swiss Biotech
Pureos Bioventures is a venture capital fund to exclusively invest in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. ... Type of organization. …See details»
Pureos Bioventures - EU-Startups
Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs …See details»
Pureos Bioventures - Investor Profile, Portfolio & Team - Tracxn
Nov 4, 2024 Co-investors of Pureos Bioventures. Over the past . 5 years, 122 investors have co-invested in Pureos Bioventures's portfolio companies.. This includes funds and angels.Invested before Pureos Bioventures: Redalpine, Schroders Capital and ; 53 others have invested in rounds before Pureos Bioventures.; There are 2 companies where Redalpine has invested before …See details»
Pureos Bioventures investment portfolio - PitchBook
Pureos Bioventures's latest investment was on 12-Nov-2024 in Alentis Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover …See details»
Pureos Bioventures at the Swiss Biotech Day
Pureos Bioventures is a venture capital fund to exclusively invest in private innovative drug development companies, with a special emphasis on the next generation of biological drugs …See details»
Pureos Bioventures - Investments, Portfolio & Company Exits
Pureos Bioventures has made 2 diversity investments. Their most recent diversity investment was on Mar 15, 2023, when Mediar Therapeutics raised. obfuscated. obfuscated. Announced Date …See details»
Pureos Bioventures | Institution Profile | Private Equity International
Pureos Bioventures. News, insights, analysis and data. Pureos Bioventures overview. Pureos Bioventures is a Switzerland-based investment firm that focuses on healthcare and life science related companies across Western Europe. AUM. Get access to Pureos Bioventures total AUM >See details»
Pureos Bioventures expands fund size to USD 205 million
Pureos Bioventures announces the final closing of its first fund BB Pureos Bioventures LP (“Pureos”) with a committed capital of USD 205 million. Pureos will exclusively invest in …See details»
Pureos Bioventures - Funding, Financials, Valuation & Investors
Pureos Bioventures has raised a total of $205M in a single venture fund, BB Pureos Bioventures LP. This fund was announced on Sep 23, 2020 and raised a total of . obfuscated. obfuscated. Unlock for free . Funds Raised. Edit Funds Raised Section. Number of …See details»
Pureos Bioventures expands the team with venture partners
Sep 21, 2021 Pureos Bioventures, a venture capital fund dedicated to support private biotech companies developing novel therapies, announced the appointment of several venture …See details»
Dominik Escher – Managing Partner, Pureos Bioventures
Nov 29, 2024 Pureos Bioventures is exclusively focused on drug development, with an emphasis on biologics, particularly protein-based therapeutics and antibodies. We currently operate two funds. The first, a $205 million fund, has been fully allocated across 18 biotech companies, with approximately 80% of these investments in Europe, and a strong focus on …See details»
BB Pureos Bioventures: Fund Performance - PitchBook
BB Pureos Bioventures Investments (11) BB Pureos Bioventures has made a total of 11 investments. Its most recent deal was a () with Hummingbird Bioscience for .The deal was …See details»
Carey Olsen and Northern Trust advise Pureos Bioventures
May 10, 2021 Pureos, which exceeded its initial fundraising target after securing support from pharmaceutical and biotech companies, family offices, pension funds, fund-of-funds, a large …See details»
Pureos Bioventures closes first fund with USD 170 million
Sep 23, 2020 Pureos Bioventures, a newly formed venture capital firm, advised by Bellevue Asset Management, announced the closing of its first fund BB Pureos Bioventures LP …See details»
Pureos Bioventures expands the team by the appointment of …
Pureos Bioventures, a venture capital fund dedicated to support private biotech companies developing novel therapies, announced the appointment of several venture partners to its …See details»
Pureos Bioventures Investor Information - Funding, Portfolio …
Pureos Bioventures is a venture capital fund based in Zürich, investing in early and growth-stage companies in the biotech, health tech, and pharma sectors. They support firms developing breakthrough solutions, such as MinervaX and Memo Therapeutics. Their mission is to advance healthcare and improve lives by providing essential capital to ...See details»
Pureos Bioventures expands fund size to USD 205 million
Apr 22, 2021 Pureos Bioventures announces the final closing of its first fund BB Pureos Bioventures LP (“Pureos”) with a committed capital of USD 205 million. Pureos will exclusively …See details»
BB Pureos Bioventures Joins BaseLaunch Phase II as the First …
Jun 8, 2020 About BB Pureos Bioventures BB Pureos Bioventures is a newly formed venture capital fund, advised by Bellevue Asset Management, with offices in Zurich , London and New …See details»